- 2019 Clinical Conference
- 2018 Clinical Conference
- Past Clinical Conferences
World Anti-Doping Agency (WADA)
WADA is an independent and international organization funded by governments and the International Olympic Committee dedicated to ensuring fair and safe international sport competition.
The organization has many responsibilities, including but not limited to overseeing drug testing of participants, engaging in and publishing research on ergogenic aids, enforcing rules of international competition regarding doping.
Each year, WADA publishes lists of banned substances, breaking them down into those that are always banned versus those that are banned in and out of competition. Some substances may also only be banned in certain sports.
For more information, visit the website at www.wada-ama.org
United States Anti-Doping Agency (USADA)
USADA is the United States branch of WADA that oversees international competitors.
Excellent point-of-care resources are available for clinicians and athletes including a search tool for their specific sport and medications they may be taking. Can also apply for Therapeutic Use Exemptions (TUEs), get explanations on how tests are processed and get more information on risks of supplement use.
For more information, visit the website at www.usada.org
Seattle Criteria for Interpretation of Electrocardiography in Athletes
Published in 2012 as a collaboration between multiple sports medicine and cardiology groups as a way to distinguish truly pathologic ECG findings from adaptations seen on ECG in the trained athlete.
See full article at http://cardiology.org/projects_athletic_14_3136203759.pdf
See quick reference chart at http://learning.bmj.com/files/pdf/Seattle_Criteria.pdf
The British Medical Journal (BMJ) offers free online tutorials that review the details of the Seattle Criteria and offer quizzes to test your knowledge at https://learning.bmj.com/learning/course-intro/.html?courseId=10042239
American Heart Association’s Policy Statement regarding screening for cardiovascular disease in athletes can be found at http://circ.ahajournals.org/content/132/22/e267.full
The 2016, the Concussion in Sport Group met in Berlin to review new and current evidence regarding concussion recognition and management. They have broken down management into the 11 R’s: recognize, remove, re-evaluate, rest, rehabilitation, refer, recovery, return to sport, reconsider, residual effects and sequelae, and risk reduction.
The consensus statement can be viewed in full at http://bjsm.bmj.com/content/early/2017/04/26/bjsports-2017-097699
The CISG has also released the SCAT-5 sideline assessment tool as an update to SCAT-3 (there was no SCAT-4). The major notable changes are the inclusion of red flag signs/symptoms that should prompt concern for injury other than concussion.
The SCAT-5 is available at http://bjsm.bmj.com/content/bjsports/early/2017/04/26/bjsports-2017-097506SCAT5.full.pdf
The NCAA recommendation for skin evaluation and participation, see NCAA Sports Medicine Handbook: http://www.ncaa.org/sites/default/files/2016DIWRE_Skin_Evaluation_Form_20170327.pdf